What are the anesthetic considerations and peri‑operative management for a patient with Grover’s disease (transient acantholytic dermatosis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic Considerations for Grover's Disease

Grover's disease (transient acantholytic dermatosis) does not require specific anesthetic modifications, and standard local anesthesia protocols for dermatologic procedures can be safely employed. 1

Key Clinical Context

Grover's disease is a pruritic papulovesicular eruption primarily affecting the trunk in older males, characterized by acantholytic histologic patterns without systemic implications that would alter anesthetic management. 2 The condition itself poses no contraindications to local or general anesthesia.

Standard Anesthetic Approach

Local Anesthesia for Dermatologic Procedures

Use standard local infiltration anesthesia with lidocaine with or without epinephrine according to anatomic location. 1

  • Epinephrine addition is safe and recommended for procedures on the trunk (the typical location of Grover's disease lesions), as it provides hemostasis and prolongs anesthetic duration without risk of tissue necrosis. 1

  • Concentrations of 1:100,000 or 1:200,000 epinephrine are appropriate for most dermatologic procedures. 1

  • Buffering with sodium bicarbonate reduces injection pain and is recommended, particularly when using lidocaine with epinephrine. 1

Maximal Barrier Precautions

If performing procedures requiring central venous access or neuraxial anesthesia, employ full aseptic technique including sterile gloves, gown, cap, mask, and large sterile drape with alcoholic chlorhexidine or povidone-iodine skin preparation. 1

Dermatologic Considerations

Skin Integrity Assessment

Patients with severe dermatitis or active skin lesions warrant careful evaluation for latex allergy risk. 1

  • Grover's disease patients may have concurrent dermatologic conditions or severe pruritus leading to excoriated skin. 2

  • Those with severe hand dermatitis are at increased risk for latex sensitization (approximately 8% of the population is sensitized, though only 1.4% exhibit true allergy). 1

  • Conduct thorough pre-operative assessment asking specifically about reactions to balloons, condoms, or latex gloves causing itching, rash, or angioedema. 1

Latex Precautions if Indicated

If latex allergy is suspected or confirmed, implement strict latex-free protocols: 1

  • Use only synthetic gloves for all patient contact
  • Schedule as first case to minimize airborne latex particle exposure
  • Post "Latex allergy" notices on procedure room doors
  • Ensure all equipment, dressings, and tapes are latex-free
  • Document allergy prominently in medical records and on patient identification

Post-Procedure Wound Care

Use bland, fragrance-free emollients or petrolatum-based products for wound care. 3

  • Avoid fragranced products, alcohol-based lotions, and excessive antiseptic creams that can irritate healing skin. 3

  • Keep treated areas clean and gently pat dry between applications. 3

  • Do not use prophylactic topical antibiotics for clean procedural wounds; reserve antibiotics for clinical signs of infection, and avoid neomycin-containing preparations. 3

Critical Pitfalls to Avoid

Do not assume Grover's disease requires modified anesthetic dosing or special drug selection—the condition is purely dermatologic without systemic effects on drug metabolism or cardiovascular function. 2

Do not confuse pruritic trunk lesions with systemic disease—while Grover's disease has been associated with hematologic malignancies in some reports, the skin condition itself does not alter anesthetic risk. 2

Do not overlook concurrent conditions—patients with Grover's disease may have other dermatologic conditions (including severe dermatitis) that increase latex allergy risk, requiring specific precautionary measures. 1

Monitoring and Safety

Standard local anesthetic toxicity monitoring applies: 1

  • Watch for circumoral numbness, facial tingling, metallic taste, or auditory changes indicating early toxicity
  • Calculate maximum safe doses to prevent errors (though dermatologic procedures typically use well below toxic doses)
  • Have resuscitation equipment immediately available

For patients with stable cardiac disease requiring epinephrine-containing anesthetics, consultation with cardiology is reasonable if uncertainty exists, though small amounts used in dermatologic surgery are generally well-tolerated. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Grover disease (transient acantholytic dermatosis).

Archives of pathology & laboratory medicine, 2009

Guideline

Post-Fraxel Laser Treatment Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.